Iranian Journal of Pediatrics

Published by: Kowsar

Clinical Characteristics of Peripheral Neuroblastic Tumors in Children: A Single-Center Experience of 43 Cases

Xiaokun Lin 1 , 2 , Guorong He 2 , Congde Chen 2 and Zhongrong Li 2 , *
Authors Information
1 Department of Pediatric Surgery, Qilu Hospital of Shandong University, Jinan, China
2 Department of Pediatric Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China
Article information
  • Iranian Journal of Pediatrics: 28 (6); e68834
  • Published Online: November 17, 2018
  • Article Type: Research Article
  • Received: March 21, 2018
  • Revised: September 24, 2018
  • Accepted: September 28, 2018
  • DOI: 10.5812/ijp.68834

To Cite: Lin X, He G , Chen C , Li Z . Clinical Characteristics of Peripheral Neuroblastic Tumors in Children: A Single-Center Experience of 43 Cases, Iran J Pediatr. Online ahead of Print ; 28(6):e68834. doi: 10.5812/ijp.68834.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Luksch R, Castellani MR, Collini P, De Bernardi B, Conte M, Gambini C, et al. Neuroblastoma (Peripheral neuroblastic tumours). Crit Rev Oncol Hematol. 2016;107:163-81. doi: 10.1016/j.critrevonc.2016.10.001. [PubMed: 27823645].
  • 2. Tadeo I, Berbegall AP, Navarro S, Castel V, Noguera R. A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors. Pediatr Blood Cancer. 2017;64(9). doi: 10.1002/pbc.26449. [PubMed: 28121069].
  • 3. Merrihew LE, Fisher PG, Effinger KE. Divergent patterns of incidence in peripheral neuroblastic tumors. J Pediatr Hematol Oncol. 2015;37(7):502-6. doi: 10.1097/MPH.0000000000000383. [PubMed: 26133942].
  • 4. Janoueix-Lerosey I, Schleiermacher G, Delattre O. Molecular pathogenesis of peripheral neuroblastic tumors. Oncogene. 2010;29(11):1566-79. doi: 10.1038/onc.2009.518. [PubMed: 20101209].
  • 5. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group. Cancer. 2001;92(9):2451-61. doi: 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S. [PubMed: 11745303].
  • 6. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, et al. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: A report from the International Neuroblastoma Risk Group project. J Clin Oncol. 2014;32(28):3169-76. doi: 10.1200/JCO.2014.56.1621. [PubMed: 25154816]. [PubMed Central: PMC4171360].
  • 7. Schulte JH, Eggert A. Neuroblastoma. Crit Rev Oncog. 2015;20(3-4):245-70. doi: 10.1615/CritRevOncog.2015014033. [PubMed: 26349419].
  • 8. Jackson JR, Tran HC, Stein JE, Shimada H, Patel AM, Marachelian A, et al. The clinical management and outcomes of cervical neuroblastic tumors. J Surg Res. 2016;204(1):109-13. doi: 10.1016/j.jss.2016.04.030. [PubMed: 27451875].
  • 9. Zimling ZG, Rechnitzer C, Rasmussen M, Petersen BL. Peripheral neuroblastic tumours in eastern Denmark 1972-2002. APMIS. 2007;115(1):66-74. doi: 10.1111/j.1600-0463.2007.apm_355.x. [PubMed: 17223852].
  • 10. Sung KW, Yoo KH, Koo HH, Kim JY, Cho EJ, Seo YL, et al. Neuroblastoma originating from extra-abdominal sites: Association with favorable clinical and biological features. J Korean Med Sci. 2009;24(3):461-7. doi: 10.3346/jkms.2009.24.3.461. [PubMed: 19543510]. [PubMed Central: PMC2698193].
  • 11. Alvi S, Karadaghy O, Manalang M, Weatherly R. Clinical manifestations of neuroblastoma with head and neck involvement in children. Int J Pediatr Otorhinolaryngol. 2017;97:157-62. doi: 10.1016/j.ijporl.2017.04.013. [PubMed: 28483228].
  • 12. Ikeda H, Iehara T, Tsuchida Y, Kaneko M, Hata J, Naito H, et al. Experience with international neuroblastoma staging system and pathology classification. Br J Cancer. 2002;86(7):1110-6. doi: 10.1038/sj.bjc.6600231. [PubMed: 11953858]. [PubMed Central: PMC2364166].
  • 13. Simon T, Hero B, Schulte JH, Deubzer H, Hundsdoerfer P, von Schweinitz D, et al. 2017 GPOH guidelines for diagnosis and treatment of patients with neuroblastic tumors. Klin Padiatr. 2017;229(3):147-67. doi: 10.1055/s-0043-103086. [PubMed: 28561228].
  • 14. Esposito MR, Aveic S, Seydel A, Tonini GP. Neuroblastoma treatment in the post-genomic era. J Biomed Sci. 2017;24(1):14. doi: 10.1186/s12929-017-0319-y. [PubMed: 28178969]. [PubMed Central: PMC5299732].
  • 15. Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078. doi: 10.1038/nrdp.2016.78. [PubMed: 27830764].
  • 16. Ahmed AA, Zhang L, Reddivalla N, Hetherington M. Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors. Pediatr Hematol Oncol. 2017;34(3):165-85. doi: 10.1080/08880018.2017.1330375. [PubMed: 28662353].
  • 17. Castel V, Villamon E, Canete A, Navarro S, Ruiz A, Melero C, et al. Neuroblastoma in adolescents: Genetic and clinical characterisation. Clin Transl Oncol. 2010;12(1):49-54. doi: 10.1007/s12094-010-0466-z. [PubMed: 20080471].
  • 18. Juskaite A, Tamuliene I, Rascon J. Results of neuroblastoma treatment in Lithuania: A single centre experience. Acta Med Litu. 2017;24(2):128-37. doi: 10.6001/actamedica.v24i2.3494. [PubMed: 28845131]. [PubMed Central: PMC5566952].
  • 19. Aydn GB, Kutluk MT, Yalcn B, Buyukpamukcu M, Kale G, Varan A, et al. Neuroblastoma in Turkish children: Experience of a single center. J Pediatr Hematol Oncol. 2009;31(7):471-80. doi: 10.1097/MPH.0b013e3181a6dea4. [PubMed: 19564739].
  • 20. Qureshi SS, Kembhavi S, Ramadwar M, Chinnaswamy G, Laskar S, Talole S, et al. Outcome and morbidity of surgical resection of primary cervical and cervicothoracic neuroblastoma in children: A comparative analysis. Pediatr Surg Int. 2014;30(3):267-73. doi: 10.1007/s00383-013-3431-4. [PubMed: 24264427].
  • 21. Brodeur GM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006. p. 933-70.
  • 22. Stefanowicz J, Izycka-Swieszewska E, Drozynska E, Pienczk J, Polczynska K, Czauderna P, et al. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics. Folia Neuropathol. 2008;46(3):176-85. [PubMed: 18825593].
  • 23. Angelini P, Plantaz D, De Bernardi B, Passagia JG, Rubie H, Pastore G. Late sequelae of symptomatic epidural compression in children with localized neuroblastoma. Pediatr Blood Cancer. 2011;57(3):473-80. doi: 10.1002/pbc.23037. [PubMed: 21548008].
  • 24. Han W, Wang HM. Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma. World J Gastroenterol. 2015;21(25):7929-32. doi: 10.3748/wjg.v21.i25.7929. [PubMed: 26167095]. [PubMed Central: PMC4491982].
  • 25. Berthold F, Spix C, Kaatsch P, Lampert F. Incidence, survival, and treatment of localized and metastatic neuroblastoma in Germany 1979 - 2015. Paediatr Drugs. 2017;19(6):577-93. doi: 10.1007/s40272-017-0251-3. [PubMed: 28786082]. [PubMed Central: PMC5680382].
  • 26. Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S. Epidemiological and clinical characteristics of neuroblastoma in southern Iran. Iran J Ped Hematol Oncol. 2014;4(3):89-96. [PubMed: 25254086]. [PubMed Central: PMC4173027].
  • 27. Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, et al. Guidelines for imaging and staging of neuroblastic tumors: Consensus report from the International Neuroblastoma Risk Group project. Radiology. 2011;261(1):243-57. doi: 10.1148/radiol.11101352. [PubMed: 21586679].
  • 28. Grouzmann E, Lamine F. Determination of catecholamines in plasma and urine. Best Pract Res Clin Endocrinol Metab. 2013;27(5):713-23. doi: 10.1016/j.beem.2013.06.004. [PubMed: 24094641].
  • 29. Mei H, Wang Y, Lin Z, Tong Q. The mTOR signaling pathway in pediatric neuroblastoma. Pediatr Hematol Oncol. 2013;30(7):605-15. doi: 10.3109/08880018.2013.798058. [PubMed: 23697980].
  • 30. Sun W, Modak S. Emerging treatment options for the treatment of neuroblastoma: Potential role of perifosine. Onco Targets Ther. 2012;5:21-9. doi: 10.2147/OTT.S14578. [PubMed: 22419878]. [PubMed Central: PMC3299554].
  • 31. Modak S, Cheung NK. Neuroblastoma: Therapeutic strategies for a clinical enigma. Cancer Treat Rev. 2010;36(4):307-17. doi: 10.1016/j.ctrv.2010.02.006. [PubMed: 20227189].
  • 32. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: An INRG task force report. J Clin Oncol. 2009;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. [PubMed: 19047291]. [PubMed Central: PMC2650388].
  • 33. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The International Neuroblastoma Risk Group (INRG) staging system: An INRG task force report. J Clin Oncol. 2009;27(2):298-303. doi: 10.1200/JCO.2008.16.6876. [PubMed: 19047290]. [PubMed Central: PMC2650389].
  • 34. Acker SN, Bruny JL, Garrington TP, Partrick DA. Minimally invasive surgical techniques are safe in the diagnosis and treatment of pediatric malignancies. Surg Endosc. 2015;29(5):1203-8. doi: 10.1007/s00464-014-3795-0. [PubMed: 25159642].
  • 35. Leclair MD, de Lagausie P, Becmeur F, Varlet F, Thomas C, Valla JS, et al. Laparoscopic resection of abdominal neuroblastoma. Ann Surg Oncol. 2008;15(1):117-24. doi: 10.1245/s10434-007-9499-0. [PubMed: 17926102].
  • 36. Boutros J, Bond M, Beaudry P, Blair GK, Skarsgard ED. Case selection in minimally invasive surgical treatment of neuroblastoma. Pediatr Surg Int. 2008;24(10):1177-80. doi: 10.1007/s00383-008-2240-7. [PubMed: 18716783].
  • 37. Park JR, Eggert A, Caron H. Neuroblastoma: Biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010;24(1):65-86. doi: 10.1016/j.hoc.2009.11.011. [PubMed: 20113896].
  • 38. Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, et al. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: A randomised controlled trial. Lancet Oncol. 2005;6(9):649-58. doi: 10.1016/s1470-2045(05)70291-6.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments